Sepsis is associated with elevated serum levels of IFNs (Schulte et al., 2013) and MS patients are treated with recombinant IFN-β, allowing analysis of the in vivo effect of IFNs on PD-L1 variant 1 and CD274-L2A expression. The gene discussed is IFNB1; the disease is myeloid sarcoma.